Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Bos · SciRah

Researcher profile · Semantic Scholar

M. Bos

Share profile

M. Bos — researcher profile on SciRah

h-index: 14
Works: 31
Citations: 4,175

Most-cited papers

Comprehensive genomic profiles of small cell lung cancer
J. George, Jing S. Lim, S. Jang, Yupeng Cun +92 more
2015Nature2,113 citations Open access
Semantic Scholar
A Genomics-Based Classification of Human Lung Tumors
D. Seidel, T. Zander, L. Heukamp, M. Peifer +112 more
2013Science Translational Medicine434 citations Open access
Semantic Scholar
CD74-NRG1 fusions in lung adenocarcinoma.
L. Fernandez-Cuesta, D. Plenker, H. Osada, R. Sun +47 more
2014Cancer Discovery268 citations
Semantic Scholar
Rationale for co-targeting IGF-1R and ALK in ALK fusion positive lung cancer
C. Lovly, Nerina T. McDonald, Heidi Chen, S. Ortiz-Cuàran +35 more
2014Nature Medicine267 citations Open access
Semantic Scholar
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
S. Ortiz-Cuàran, M. Scheffler, D. Plenker, Llona Dahmen +32 more
2016Clinical Cancer Research240 citations Open access
Semantic Scholar
MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung
H. Schildhaus, A. Schultheis, J. Rüschoff, E. Binot +20 more
2014Clinical Cancer Research178 citations
Semantic Scholar
PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies
M. Scheffler, M. Bos, M. Gardizi, K. König +25 more
2014OncoTarget144 citations Open access
Semantic Scholar
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer
H. Schildhaus, L. Heukamp, S. Merkelbach-Bruse, K. Riesner +26 more
2012Modern Pathology126 citations Open access
Semantic Scholar
Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer
A. Schultheis, M. Bos, K. Schmitz, Lea Wilsberg +4 more
2014Modern Pathology99 citations Open access
Semantic Scholar
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.
F. Malchers, Felix Dietlein, Jakob Schöttle, Xin Lu +29 more
2014Cancer Discovery97 citations
Semantic Scholar
Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients
Katharina König, M. Peifer, J. Fassunke, M. Ihle +31 more
2015Journal of Thoracic Oncology87 citations Open access
Semantic Scholar
Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib.
M. Bos, M. Gardizi, H. Schildhaus, L. Heukamp +11 more
2013Lung Cancer48 citations Open access
Semantic Scholar
Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient.
M. Scheffler, S. Merkelbach-Bruse, M. Bos, J. Fassunke +13 more
2015Journal of Thoracic Oncology32 citations Open access
Semantic Scholar
Activated RET and ROS: two new driver mutations in lung adenocarcinoma.
M. Bos, M. Gardizi, H. Schildhaus, R. Buettner +1 more
2013Translational Lung Cancer Research15 citations
Semantic Scholar
Regional screening network for characterization of the molecular epidemiology of non-small cell lung cancer (NSCLC) and implementation of personalized treatment.
Thomas Zander, L. Heukamp, M. Bos, J. Fassunke +16 more
2012Journal of Clinical Oncology12 citations
Semantic Scholar
TRY: A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation.
L. Nogova, M. Gardizi, M. Bos, M. Scheffler +14 more
20144 citations
Semantic Scholar
SORAVE: Sorafenib and everolimus for treatment of patients with relapsed solid tumors and with KRAS mutated NSCLC—A phase I study.
L. Nogova, C. Mattonet, M. Gardizi, M. Scheffler +16 more
20133 citations
Semantic Scholar
SORAVE: Phase I study for the treatment of relapsed solid tumors with the combination of sorafenib and everolimus.
L. Nogova, C. Mattonet, M. Scheffler, M. Bos +16 more
20123 citations
Semantic Scholar
Ampli fi cation Status in Therapy-Naïve Adeno-and Squamous Cell Carcinomas of the Lung
H. Schildhaus, A. Schultheis, R. Josef, uschoff +20 more
20152 citations
Semantic Scholar
1238PTRY - A PHASE II STUDY TO EVALUATE SAFETY AND EFFICACY OF COMBINED TRASTUZUMAB AND THE HSP90 INHIBITOR AUY922 IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) WITH HER2 OVEREXPRESSION OR AMPLIFICATION OR MUTATION.
L. Nogova, C. Mattonet, Matthias Scheffler, S. Michels +14 more
2014Annals of Oncology2 citations Open access
Semantic Scholar
BARIS: A phase I trial to evaluate the safety and tolerability of combined BIBF 1120 and RAD001 in solid tumors and to determine the maximum tolerated dose (MTD) of the combination.
M. Scheffler, L. Nogova, M. Gardizi, M. Bos +5 more
20122 citations
Semantic Scholar
High-throughput parallel amplicon sequencing of common driver mutations from FFPE lung cancer samples in molecular pathologic routine diagnostics for a regional health care provider network.
R. Buettner, Katharina Koenig, M. Peifer, Katrin Stamm +8 more
20131 citations
Semantic Scholar
Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer
C. Lovly, Nerina T. McDonald, Heidi Chen, S. Ortiz-Cuàran +35 more
2025Nature Medicine0 citations Open access
Semantic Scholar
Abstract 752: Elucidating the mechanisms of acquired resistance in lung adenocarcinomas
S. Ortiz-Cuàran, L. Fernandez-Cuesta, C. Lovly, M. Bos +21 more
20150 citations
Semantic Scholar
Abstract 956: Elucidating the mechanisms of acquired resistance in lung adenocarcinomas
S. Ortiz-Cuàran, L. Fernandez-Cuesta, M. Bos, L. Heukamp +14 more
20140 citations
Semantic Scholar
Abstract 441: Functional characterization of recurrent CD74‐NRG1 fusions in lung adenocarcinoma
D. Plenker, L. Fernandez-Cuesta, H. Osada, R. Sun +9 more
20140 citations
Semantic Scholar
MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET, DCE-MRI and molecular biomarkers for early prediction of nonprogression in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab.
M. Scheffler, M. Bos, M. Sos, L. Heukamp +15 more
20140 citations
Semantic Scholar
Association of PIK3CA mutations and age with the occurence of second primary lung cancer (SPLC).
M. Bos, M. Gardizi, M. Scheffler, L. Nogova +16 more
20130 citations
Semantic Scholar
MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET and DCE-MRI for early prediction of efficacy in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab.
M. Scheffler, M. Bos, M. Sos, L. Nogova +16 more
20120 citations
Semantic Scholar
Clinical characteristics and natural history of patients with squamous cell lung carcinoma with FGFR1 amplification.
M. Bos, M. Gardizi, L. Heukamp, H. Schildhaus +16 more
20120 citations
Semantic Scholar
Frequency and clinical characterization of NSCLC patients harboring PIK3CA mutations identified within a regional screening network.
M. Gardizi, M. Scheffler, L. Heukamp, M. Bos +16 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Heukamp×24
Invite
L. Heukamp — researcher profile on SciRah
M. Gardizi×21
Invite
M. Gardizi — researcher profile on SciRah
R. Buettner×18
Invite
R. Buettner — researcher profile on SciRah
T. Zander×17
Invite
T. Zander — researcher profile on SciRah

×17

Invite

J. Wolf — researcher profile on SciRah

M. Scheffler×17

Invite

M. Scheffler — researcher profile on SciRah

Invite

L. Nogova — researcher profile on SciRah

H. Schildhaus×11

Invite

H. Schildhaus — researcher profile on SciRah

Invite

J. Wolf — researcher profile on SciRah

S. Merkelbach-Bruse×11

Invite

S. Merkelbach-Bruse — researcher profile on SciRah

Invite

Y. Ko — researcher profile on SciRah

Invite

S. Ansén — researcher profile on SciRah